Conducting rare disease clinical trials is complex. Incorporating genetic testing and the resulting data can introduce nuances and complications that increase the complexity even more. Understanding the unique obstacles and how to strategically navigate them is a key to clinical trial success.
In this whitepaper, InformedDNA shares strategies for overcoming primary challenges, including:
InformedDNA is the largest full-service genetic advisory company in the U.S., with a suite of offerings for sponsors and CROs designed to support clinical trials, natural history studies, and clinical research programs. Our services are optimized to reduce time to enrollment, increase screening efficiencies, improve patient retention, mitigate sponsor risk, and reduce clinical trial costs.